Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2

Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2


Authors: 
Mina Psichogiou, Michael Samarkos, Nikolaos Mikos, and Angelos Hatzakis

Abstract:
Seven immunocompetent patients aged > 50 years old presented with herpes zoster (HZ) infection in a median of 9 days (range 7–20) after vaccination against SARS-CoV-2. The occurrence of HZ within the time window 1–21 days after vaccination defined for increased risk and the reported T cell-mediated immunity involvement suggest that COVID-19 vaccination is a probable cause of HZ.
These cases support the importance of continuing assessment of vaccine safety during the ongoing
massive vaccination for the COVID-19 pandemic and encourage reporting and communication of
any vaccination-associated adverse event.

Comentarios

Entradas populares de este blog

La biopsia cutánea en la urticaria crónica: cuándo realizarla, qué buscar y dónde hacerlo

The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria

Managing Food Allergy When the Patient Is Not Highly Allergic